Inventor · disambiguated record
Harold C. Smith
Also filed as: SMITH HAROLD B · SMITH HAROLD C · SMITH HAROLD CALE
18 granted patents·16 pending applications·146 citations·filing 1992–2023
92Inventor score
Top patents by PatentIndex Score
34 records- 0184US11782050B2Cell-based assay for quantifying the potency and efficacy of cannabinoids and/or terpenoids, and methods of use thereofCANNAMETRIX LLC·Filed 2018·Granted Oct 10, 2023·2 cites·34 claims
- 0282US12436146B2Cell-based assay for quantifying the potency and efficacy of cannabinoids and/or terpenoids, and methods of use thereofCANNAMETRIX LLC·Filed 2023·Granted Oct 7, 2025·0 cites·21 claims
- 0382US8334255B2Peptide and treatment for HIV-1 infectionZHANG HUI·Filed 2007·Granted Dec 18, 2012·2 cites·22 claims
- 0478US8501668B2Drug screening via nanopore silicon filtersMCGRATH JAMES L·Filed 2010·Granted Aug 6, 2013·4 cites·16 claims
- 0577US11617753B2Methods of treating and inhibiting Ebola virus infectionOYAGEN INC·Filed 2017·Granted Apr 4, 2023·1 cites·4 claims
- 0676US8158770B2Content dependent inhibitors of cytidine deaminases and uses thereofWEDEKIND JOSEPH E·Filed 2005·Granted Apr 17, 2012·7 cites·24 claims
- 0774US10588902B2Camptothecin derivatives as anti-HIV agents and methods of identifying agents that disrupt Vif self-associationOYAGEN INC·Filed 2014·Granted Mar 17, 2020·2 cites·2 claims
- 0873US5487517ARemovable hangerFiled 1994·Granted Jan 30, 1996·39 cites·2 claims
- 0967US11779585B2Method for treating coronavirus infectionsOYAGEN INC·Filed 2022·Granted Oct 10, 2023·0 cites·18 claims
- 1061US5395080ARemovable hangerFiled 1993·Granted Mar 7, 1995·26 cites·7 claims
- 1161US2022000860A1Compounds, compositions, and methods for treating human immunodeficiency virusOYAGEN INC·Filed 2021·Application pending·0 cites
- 1260US11738025B2Method for treating coronavirus infectionsOYAGEN INC·Filed 2020·Granted Aug 29, 2023·0 cites·15 claims
- 1360US5181683ARemovable hangerSMITH HAROLD C·Filed 1992·Granted Jan 26, 1993·28 cites·8 claims
- 1460US2020338067A1Camptothecin derivatives as anti-hiv agents and methods of identifying agents that disrupt vif self-associationOYAGEN INC·Filed 2020·Application pending·0 cites
- 1558US2010160174A1Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereofUNIV ROCHESTER MEDICAL CT·Filed 2009·Application pending·0 cites
- 1657US11116762B2Compounds, compositions, and methods for treating human immunodeficiency virusOYAGEN INC·Filed 2018·Granted Sep 14, 2021·0 cites·16 claims
- 1757US2005287648A1Protein Transducing Domain/Deaminase Chimeric Proteins, Related Compounds, and Uses ThereofUNIV ROCHESTER·Filed 2003·Application pending·0 cites
- 1855US5364050AHanger for latticeSMITH HAROLD C·Filed 1993·Granted Nov 15, 1994·23 cites·9 claims
- 1951US2023233591A1Method for treating poxviridae infectionsOYAGEN INC·Filed 2021·Application pending·0 cites
- 2051US2023285434A1Method for treating arenaviridae infectionsOYAGEN INC·Filed 2021·Application pending·0 cites
- 2150US2006149658A1Construction contract biddingSMITH HAROLD B·Filed 2005·Application pending·0 cites
- 2249US8841068B2Human immunodeficiency virus antiviral screening assay involving the detection of CEM15 expressionSMITH HAROLD C·Filed 2006·Granted Sep 23, 2014·0 cites·4 claims
- 2348US2009075925A1Methods and Compositions Related to APOBEC-1 ExpressionSMITH HAROLD C·Filed 2007·Application pending·0 cites
- 2448US2010100976A1Methods and compositions related to apobec-1 expressionUNIV ROCHESTER·Filed 2007·Application pending·0 cites
- 2547US2015272959A1Small molecules as anti-hiv agents that disrupt vif self-association and methods of use thereofOYAGEN INC·Filed 2013·Application pending·0 cites
- 2646US8999317B2Methods and compositions related to the structure and function of APOBEC3GSMITH HAROLD C·Filed 2007·Granted Apr 7, 2015·0 cites·6 claims
- 2746US2004115184A1Methods and compositions for modifying apolipoprotein b mrna editingFiled 2002·Application pending·0 cites
- 2844US2015018380A1Methods of Screening for Activation Deaminase Inhibitors Through Nuclear Import InhibitorsSMITH HAROLD C·Filed 2013·Application pending·0 cites
- 2944US2005112555A1Cytidine deaminase activators, deoxycytidine deaminase activators, Vif antagonists, and methods of screening for molecules thereofFiled 2004·Application pending·0 cites
- 3042US2010297219A1Methods and Compositions for Modifying Apolipoprotein B mRNA EditingUNIV ROCHESTER MEDICAL CT·Filed 2010·Application pending·0 cites
- 3140US12227784B2Enzyme blends and processes for improving the nutritional quality of animal feedNOVOZYMES AS·Filed 2018·Granted Feb 18, 2025·0 cites·24 claims
- 3240US5657953AOperable hangerFiled 1995·Granted Aug 19, 1997·12 cites·14 claims
- 3337US2013123285A1Compositions and Methods for Targeting A3G:RNA ComplexesSMITH HAROLD C·Filed 2011·Application pending·0 cites
- 3433US2012271036A1Solution Assay and High Through-Put Screen to Probe Interaction Between Human Cullin-Ring Ligase Complex and HIV-VIF ProteinSMITH HAROLD C·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Harold C. Smith files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →